Marseille Immunopole ©2019 Legal notice & Privacy statement
To date, The Pioneer Project benefits from the commitment of 12 partner centers.
When PIONeeR meets QUANTIC
Meet our experts involved in the Pioneer Project
Highlights of the event: “MI Day Lung Cancer”
An update of The Pioneer Project RHU: 148 patients entered in the biomarker program, 7 patients in the umbrella clinical trial
As COVID19 pandemic continues, all partners remain at work and committed to The Pioneer Project
An update of The Pioneer Project RHU: 104 patients in the biomarker component, 2 patients in the umbrella clinical trial.
MI Day: “MI Day Lung Cancer” on 6 February 2020
Immuno-oncology and lung cancer highlights: episode 2 (Q4 2019)
Update of the Pioneer Project RHU: while 91 patients have already been included in the biomarker component of the project, a first patient is entered in the Pioneer’s clinical trial
Overcome resistance to anti-PD1(L1) immunotherapy: first lung cancer patient enrolled in the Pioneer Project’s clinical trial